The white paper describes the top 5 investment, regulatory, product development and regional trends in the next-generation sequencing market. Kalorama covers next-generation sequencing in its report, Next Generation Sequencing Market.
Sections in this white paper include:
- Investors Continue to Bet on NGS
- Clinical Opportunity in Three Areas
- NGS-IVD
- Regulatory Picture Getting Clearer
- China a Major NGS Player in 2016
Fill out the form to learn more.
